Navigation Links
MedApps Receives FDA Clearance on a New Way to Bring Cost-Effective Remote Health Monitoring to More People
Date:6/9/2009

MedApps' Innovative Personal Health Device: A Key to Lowering Healthcare Costs and Expanding Viability and Adoption of Electronic Health Records

SCOTTSDALE, Ariz., June 9 /PRNewswire/ -- Health professionals and patients alike have access to a new set of tools that will aid in stabilizing mounting healthcare costs by increasing compliance. MedApps, Inc. has been granted a 510(k) market clearance by the U.S. Food and Drug Administration for its expanded, flexible telehealth solution.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090609/LA28821 )

The MedApps system is designed to link patients, families and healthcare professionals by providing a convenient way to remotely collect, transmit, store and report timely and accurate health information -- anywhere.

The MedApps system features the HealthPAL, a small portable personal health device, to collect and transmit readings from glucose meters, blood pressure monitors, weight scales and pulse oximeters. Timely health readings from these devices are useful in maintaining wellness regimens and can assist clinicians in their treatment of patients with chronic diseases. The collected data is automatically transmitted to a secure central server where it can be accessed by healthcare professionals or stored to an online electronic personal health record such as Microsoft(R) HealthVault(TM) or Google(TM) Health.

HealthPAL is simple to use and ready to go "out of the box". It eliminates the need for specialized hardware, expensive cellular plans, or computers to collect and transmit biometric readings. The ease of use is a key factor in improving patient compliance. Initial results from pilot programs using the MedApps solution, including those in place with Cleveland Clinic and Baptist Home Health Network, have been very encouraging.

"Our entire system is designed around a single criterion -- increasing patient compliance," said Kent Dicks, MedApps Founder & CEO. "Patient compliance is greatly dependent on simplicity, and simplicity helps drive costs down and reliability up. It's key in keeping patients engaged and healthcare costs in check, and it's no coincidence that we have significantly improved patient compliance in all of our pilots."

The MedApps system offers healthcare professionals the opportunity to monitor patient conditions and manage diseases at earlier stages when associated expenses are lower. Additionally, the system provides patients with more user friendly tools, which enables them to take a more active role in their own health management.

About MedApps

MedApps is dedicated to providing innovative solutions for the collection, transmission and management of remote-monitored patient data. The company is recognized as a telehealth industry leader, winning the Nokia MobileRules Competition, as well as receiving the Frost & Sullivan North American Technology Innovation Award for Wireless Point of Care and being selected a finalist of the Dell / NFIB Excellence Award. www.medapps.com

    Media Contact:
    Randy Strength
    MedApps, Inc.
    (480) 305-6323
    Randy.strength@medapps.net


'/>"/>
SOURCE MedApps
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedApps HealthPAL Connects to Microsoft HealthVault to Improve Patient Compliance and Lower Healthcare Costs
2. MedApps Wins Nokia 2008 Mobile Rules! Business Plan Competition Award
3. MedApps Receives Prestigious Frost & Sullivan Award
4. Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
5. Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device
6. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
7. XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
8. Cepheid Receives Health Canada License for Xpert(R) HemosIL(R) FII & FV Test
9. Innovia Receives FDA Clearance For The InnoPort(TM)
10. Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM)
11. Respected Surgeon Receives Emmy Nomination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: